106 results about "Female reproductive system" patented technology

The present invention relates to methods of identifying a disease treatable with PARP modulators by identifying a level of PARP in a sample of a subject, making a decision regarding identifying the disease treatable by the PARP modulators wherein the decision is made based on the level of PARP. The method further comprises of treating the disease in the subject with the PARP modulators. The methods relate to identifying up-regulated PARP in a disease and making a decision regarding the treatment of the disease with PARP inhibitors. The extent of PARP up-regulation in a disease can also help in determining the efficacy of the treatment with PARP inhibitors. The present invention discloses various diseases that have up-regulated or down-regulated PARP and can be treated with PARP inhibitors or PARP activators, respectively. The examples of the diseases include cancer, inflammation, metabolic disease, CVS disease, CNS disease, disorder of hematolymphoid system, disorder of endocrine and neuroendocrine, disorder of urinary tract, disorder of respiratory system, disorder of female reproductive system, and disorder of male reproductive system.

A spaying simulation kit that allows students to practice a small animal surgical spay is provided. The spaying simulation kit includes an outer casing which may be suspended in a box. The outer casing includes a length, a width, a front end, a rear end, a top portion and a bottom portion. An internal housing is formed within the outer casing. An opening, such as a rectangular opening, may be cut through the outer casing and may thereby lead into the internal housing. The present invention may include at least one cord suspended within and running along a length of the internal housing. The cord includes a plurality of indicators that are indications of different portions of a female reproductive system.

The present invention relates to methods of identifying a disease treatable with PARP modulators by identifying a level of PARP in a plurality of samples from a population, making a decision regarding identifying the disease treatable by the PARP modulators wherein the decision is made based on the level of PARP. The method further comprises of treating the disease in a subject population with the PARP modulators. The methods relate to identifying up-regulated PARP in a disease and making a decision regarding the treatment of the disease with PARP inhibitors. The extent of PARP up-regulation in a disease can also help in determining the efficacy of the treatment with PARP inhibitors.The present invention discloses various diseases that have up-regulated or down-regulated PARP and can be treated with PARP inhibitors or PARP activators, respectively. The examples of the diseases include cancer, inflammation, metabolic disease, CVS disease, CNS disease, disorder of hematolymphoid system, disorder of endocrine and neuroendocrine, disorder of urinary tract, disorder of respiratory system, disorder of female reproductive system, and disorder of male reproductive system.

A fertility-enhancing supplement contains a balance of compositions and ingredients that will enhance the reproduction system in the female and male to help support conception, while also supporting the anti-aging of the reproductive system, taken in balance to aid in the uptake by the body of certain and particular compositions that are included in this invention. The supplement can include ingredients to assist the female reproductive system to conceive and in the male to aid in the production of more healthy sperm. Such ingredients as glucosamine sulfate are included separately or in conjunction to help the female reproductive system to maintain a youthfulness in the female and are important to the maintaining of the vitality of eggs and reducing the aging process in the development of fertilized eggs, embryos and facilitating the implantation of embryos. The supplement will help in the preservation of the eggs and the reproductive system and the overall reproductive health, as the female ages, and assist the male in sperm production throughout the child bearing years.

Described are methods for protecting the female reproductive system against natural and artificial insults by administering to women a composition comprising an agent that antagonizes one or more acid sphingomyelinase (ASMase) gene products. Specifically, methods disclosed herein serve to protect women's germline from damage resulting from cancer therapy regimens including chemotherapy or radiotherapy. In one aspect, the method preserves, enhances, or revives ovarian function in women, by administering to women a composition containing sphingosine-1-phosphate, or an analog thereof. Also disclosed are methods to prevent or ameliorate menopausal syndromes and to improve in vitro fertilization techniques.

The invention discloses antibacterial body shaping gel for regulating microecological balance and a preparation method. The body shaping gel is prepared from the following raw materials in parts by weight: 1-3 parts of hydroxyethyl cellulose, 4-6 parts of radix sophorae flavescentis extract, 3-5 parts of radix stemonae extract, 1-3 parts of collagen peptide, 3-5 parts of fructus cnidii extract, 3-5 parts of cortex phellodendri extract, 2-4 parts of pericarpium zanthoxyli fruit extract, 2-4 parts of saffron crocus extract, 2-3 parts of snow lotus herb extract, 1-3 parts of hamamelis virginianaleaf extract and 2-5 parts of lactobacillus. The body shaping gel disclosed by the invention can kill harmful pathogenic bacteria in vagina, protect the beneficial floral in vagina, regulate the microecological balance of vagina and enhance the immunity of the female reproductive system; meanwhile, the body shaping gel also has the functions of clearing the uterus and eliminating toxin, repairingthe injured mucosa of vagina, improving the flabby and dry vagina and realizing compactness.

The present invention relates to the use of a photosensitiser which is 5-ALA or a precursor or derivative thereof (e.g. an ALA ester), in the manufacture of a pharmaceutical product for use in the photodynamic treatment or diagnosis of cancer, an infection associated with cancer, or in the treatment or diagnosis of a non-cancerous condition, wherein said pharmaceutical product is in the form of a solid. The invention also relates to solid pharmaceutical products for use in such methods, e.g. suppositories, pessaries, tablets, pellets and capsules which comprise 5-ALA or a precursor or derivative thereof (e.g. an ALA ester) and at least one pharmaceutically acceptable carrier or excipient. Such products are particularly suitable for use in the photodynamic treatment or diagnosis of cancerous or non not cancerous conditions in the lower part of the gastrointestinal system or in the female reproductive system, e.g. in the treatment or diagnosis of colorectal cancer or cervical cancer.

The invention aims to provide a method for sex induction of hermaphrodite shrimps. According to the method, a target gene in macrobrachium is silenced by using an RNA interference technology to realize sex induction of macrobrachium rosenbergii, wherein the nucleotide sequence of the target gene is SEQ ID NO:1. By virtue of the induction technology provided by the invention, a macrobrachium individual has sex reversion and becomes hermaphrodite macrobrachium rosenbergii, and the developments of a female reproductive system and a male reproductive system are realized in the body of the hermaphrodite macrobrachium rosenbergii, so that a set of effective macrobrachium rosenbergii sex induction technology is established. Meanwhile, by using the hermaphrodite shrimps cultured by the method provided by the invention, a good scientific research material and an animal sample can be provided for sex determination, sex differentiation and researches on reproduction and fertilization of shrimps and crabs.

The invention discloses health care traditional Chinese medicine cosmetic capable of protecting female reproductive systems and the health of human soft tissues. The cosmetic is prepared from raw materials taxus chinensis extract liquor and taxus chinensis essential oil. Through self health care in daily nursing, the cosmetic ensures that the aim of preventing pathological changes of the female reproductive systems and the human soft tissues is achieved.

The invention discloses a traditional Chinese medicine for treating inflammation of a female reproductive system and a preparation method thereof as well as a quality control method thereof. The medicine is prepared by the following raw materials in part by weight: 200 to 300 parts of Picria fel-terrae, 350 to 450 parts of herba elephantopi, 350 to 450 parts of Caulis Spatholobi, 350 to 450 parts of Radix zanthoxyli, 350 to 450 parts of membranaceous beautyleaf root, 350 to 450 parts of persimmon leaf and 350 to 450 parts of Thlaspi. The preparation method of the medicine is characterized in that medicinal extracts are used as medicine after being made into dry powder. The medicine is preferably made into sugar coated tablets. At the same time, a quality control method for content measurement and discrimination of the medicine is provided. The general effective rate of the medicine is verified by the clinical test result to be 97.96 percent, and the general effective rate of reference drug is 96.05 percent. After the treatment with the medicine, the disease and the primary symptom are remarkably improved. The medicine has good effect on treating the vaginitis and has slight adverse reaction.

The invention relates to a pair of traditional Chinese medicine physical therapy pants for treating female reproductive system diseases, comprising a surrounding type female pants body provided with aconnecting buckle or a nylon adhering piece which is arranged at the side part and the lower part and made of soft cotton cloth materials. Parts of the pants body corresponding to the pudendum and the anus are respectively provided with a medical physical therapy patch dipped in a Chinese medicinal herb solution, and the Chinese medicinal herb solution is prepared from medicine raw materials of areca, fossil bone, cortex phellodendri, alum, stone-like omphalia, radix sophorae flavescentis, pepper, dyer woad leaf, cortex dictamni radicis, realgar, dragon blood, fructus cnidii, dandelion, pseudolarix and the like and water according to a certain proportion. The whole prescription has the functions of clearing away heat and toxic material, diminishing inflammation and relieving pain, removing dampness to relieve itching as well as protecting and cleaning the pudendum, has excellent effect of treating and preventing the female reproductive system diseases and can remarkably reduce or eliminate the threat of the disease to the health of women.

The invention discloses a sanitary napkin, toilet paper or care wings containing Taxus chinensis and preparing methods thereof. The sanitary napkin, toilet paper or care wings comprises an outer layer of permeable nonwoven cloth layer, a middle layer of fibre layer and an inner layer of netted curtain coated film layer; the fibre layer contains medicine powder made of Taxus chinensis, or the fibre layer is soaked by Taxus chinensis leaching liquor, or the netted curtain coated film later is soaked by Taxus chinensis juice, wherein the content of Taxus chinensis is 10% to 100% of the total content of medicine. The sanitary napkin, toilet paper or care wings disclosed by the invention has (have) the beneficial effects of clearing away heat and toxic materials, reducing inflammation and killing germs, eliminating dampness and stopping leukorrhagia, expelling wind and stopping itch, warming meridian and relieving pain, and has an obvious effect on treating gynecological diseases, such as vaginitis, cervicitis and the like, and has the capabilities of preventing and inhibiting gynaecologic cancers, such as cervical carcinoma, ovarian cancer and the like while dispelling inflammation, and stopping the female reproductive system from changing from inflammation to cancer.

The invention belongs to the field of medicinal preparation, relating to a temperature responsive bio-adhesive in situ gel sustained-release preparation for vagina drug administration. The preparationis composed of poloxamer, carrageenan, at least one optional gel substrate material, such as polyacrylic acid and the like and at least one drug with effective treating amount. The preparation combines the reversed-phase gelation properties of poloxamer and the bio-adhesive property and antiviral activity of carrageenan, and can obviously improve the sustained-release effect of the gel and can maintain effective drug concentration for above 12 hours in the vagina in vivio. The preparation has the advantages of convenient drug administration and favourable sustained release and is suitable fortreating diseases of female reproductive system, in particular to sexually transmitted sex microorganism infection.

The invention relates to a probiotic composition for nursing a female reproductive system. The probiotic composition is prepared from the following raw material components: lactobacillus vaginalis, lactobacillus salivarius, lactobacillus paracasei, lactobacillus acidophilus, lactobacillus reuteri, lactobacillus iners, lactobacillus crispatus and chitosan. The components are appropriately proportioned by weight to finally obtain powder having the effects of inhibiting growth of pathogenic microorganisms, relieving and treating vaginitis, restoring the self-cleaning function of the female reproductive system and improving the immunity function; the probiotic composition prevents the pathogenic microorganisms from adhering to vaginal epithelial cells through a competitive adhesion mechanism and stimulates the immune system to maintain vaginal microecological balance. The probiotic composition has the advantages that infections of pathogenic bacteria are inhibited through active probiotics, the self-treating and self-healing effect can be achieved, the restoration of a microecological balance state is promoted, and the problems of the female reproductive system are solved from the source.

Systems and methods for treating a female reproductive system are disclosed. An intrafallopian device, which may be at least partially non-conductive, is delivered to a fallopian tube. A subsequent uterine ablation may be performed. The ablation element may include insulators at portions of the ablation element contactable with a fallopian tube or intrafallopian device.

Chicken II and salmon GnRH analog decapeptides resistant to degradation by peptidase incorporating D-arginine, D-leucine, D-tBu-Serine, D-Trp or other active D amino acids at position 6 and ethylamide, aza-Gly-amide or other Gly amide at position 10. The analogs demonstrate preferential binding to male and female reproductive system GnRH receptors. Biopotency is greater within the reproductive system than at the pituitary. These non-mammalian GnRH analogs may be used in pharmaceutical preparations, and specifically in various treatment methods as a contraceptive or post-coital contraceptive agent. The non-mammalian GnRH analogs are also provided in pharmaceutical preparations that may be used clinically for maintaining pregnancy when used in very low doses and administered in pulsatile fashion, as well as in preparations for the treatment of male and female reproductive system disorders. The aza-Gly (10) amide non-mammalian analogs are yet other embodiments of the non-mammalian GnRH analogs provided as a part of the invention.

The invention provides methods for detecting and inhibiting angiogenesis, endothelial cell adhesion, and endothelial cell migration using agents which inhibit the specific binding of integrin α4β1 to one or more of its ligands. The invention further provides methods for screening test compounds for their ability to inhibit angiogenesis, endothelial cell adhesion, or endothelial cell migration by employing agents which inhibit the specific binding of integrin α4β1 to one or more of its ligands. The invention additionally relates to methods for isolating endothelial progenitor cells which express integrin α4β1. The methods of the invention are useful in, for example, diagnosing and inhibiting pathological conditions that are associated with angiogenesis, endothelial cell adhesion, and / or endothelial cell migration. The invention's methods are also useful in isolating endothelial progenitor cells, and in determining the mechanisms that underlie angiogenesis, development, wound healing, and the function of the female reproductive system.

The invention discloses a system and method for generating a pathological diagnosis report of a breast cancer and a female reproductive system. The system comprises a pathological report analysis platform and a patient's basic information which is input, wherein pathological images related to a pathological number are read from a pathological image server according to the pathological number, and then, the pathological number and the related pathological images are stored in a website form; the images are downloaded according to the website; meanwhile, macro-examination information of the pathological diagnosis report is acquired from the pathological image server; the pathological report analysis platform also receives pathological diagnosis analysis results input by a doctor and stores the analysis results in a database server, and the pathological report analysis platform also reads corresponding pathological Word template information from a document template server according to the pathological type; and the pathological diagnosis analysis results are read from the database server, and the pathological diagnosis analysis results input by the diagnosis doctor are matched with an index bookmark in the pathological Word template, so that the diagnosis doctor can generate the diagnosis report quickly.

The invention belongs to Chinese medicine preparation; the raw material formula for the preparation of the gel comprises peony, safflower, rose, mother chrysanthemum, pomegranate blossom, Campsis grandiflora, rosemary, lotus, peach blossom, China rose, honeysuckle, freshwater sponge, marigold, jasmine flower, stramonium, Flos Magnoliae officinalis, Chinese gall, radix sophorae falvescentis, Leonurus heterophyllus, purslane, myrrh, garden balsam seed and yam, the raw materials are extracted based on different weights to prepare original liquid medicine in which sodium benzoate is added as an antiseptic in a proportion of 3 per mill, carboxymethylcellulose sodium is formulated with purified water to a status that 6% thereof is substrate, the substrate is soaked uniformly and is added with the original liquid medicine in a proportion of 1:2, and after the uniform stirring, the gel is formed; the filling amount is 3g each gel; the medicine is used for treating diseases of female reproductive system, and can not only reach expelling of toxin and inflammation reduction, but also promote the shrinkage of the vagina; the invention also has the characteristics of multi-functions, no side effect, good treatment effect and convenient usage.

The present invention relates to a preparation method of rhodamine oil anti-aging summer sleeping mat, including: (1) preparation of rhodamine oil microcapsule: (a) preparation of oil-in-water emulsion, (b) coating, (c) curing; (2) confecting an anti-aging treating agent by 110-130g / L of rhodamine oil microcapsule and 30-40g / L of adhesive; (3) spraying or brushing the anti-aging treating agent on summer sleeping mat products; (4) drying at 80-95 DEG C for 15min-20min. The summer sleeping mat produced by the method has a good conditioning effect to the female reproductive system, helping to alleviate depression, gradually conditioning the skin and promoting cell regeneration, and having a certain degree of anti-bacterial function.

The invention discloses a water soluble human lubricant capable of enhancing libido. The water soluble human lubricant is mainly composed of the following major components by weight percentage: 30-45% of glycerinum, 2-4% of tween-20, 0.05-0.15% of sodium hyaluronate, 0.5-1.2% of aloe essential oil, 0.08-0.2% of clary sage essential oil, and 50-61.15% of water. The water soluble human lubricant capable of enhancing libido has good compatibility with body fluid naturally secreted by the human body, is not oily, and has a pH value which is consistent with the pH value of the normal physiological environment in the female vagina; besides, the essential oil components of the lubricant are capable of enhancing the sexual feeling of both a man and a woman, thereby improving the quality of the sexual life; and simultaneously, the lubricant has nursing and healthcare effects on the female genital system.

The invention discloses a female intimate care lubricating liquid, comprising the following components in percentage by weight: 0.1%-1% of cationic thickener, moisturizer 1%-20%, surfactant 0.1%-2%, active ingredient 1%-30%, chelate agent 0.01%-0.2%, preservative 0.05%-0.2% and 0.1%-1% of acidity and alkalinity regulator, and the balance is purify water; wherein the active ingredient is at least one of marine collagen, aloe extract, centella asiatica extract and ecological nutrient solution. The nursing lubricant can effectively solve the problems that the existing nursing lubricant has largeside effects, single product effect and damage to the female reproductive system, and can be used as the daily nursing product of women and the lubricant in the life of two sexes.

The invention discloses a manufacturing process for a medicine protective pad and a medicine combination of a medicine protective pad. The manufacturing process of the medicine protecting pad is mainly characterized in that the medicine combination is added in the protective pad; the protective pad is packaged by a capsule type sterile aluminum-plastic panel in an aluminum-plastic closed manner; and the medicine combination consists of saussurea involucrata, safflower, ructus cnidii, dried alum, radix stemonae, indigo naturalis, frankincense and semen vaccariae. In the manufacturing process of the medicine protective pad, plant extracts are subjected to spray drying to obtain concocted medicines, and the concocted medicines are high in effect, are stable and have a lasting medical effect; the medicine combination is reasonable in formula and has effective nourishing and uterus warming effects on a female reproductive system; the medicine protective pad is filled with the concocted medicines in a spraying manner; the medicine effect releases slowly; the concocted medicines have the lasting medical effect and do not have obvious odor; and the medicine protective pad is provided with an all-cotton additive-free pad surface fabric, is harmless and is safe enough for people. Moreover, the medicine protective pad is packaged by the capsule type sterile aluminum-plastic panel in the aluminum-plastic closed manner; and secondary pollution is avoided effectively.

The invention discloses a traditional Chinese medicine uterus warming paste, and is characterized in that the uterus warming paste is composed of a traditional Chinese medicine composition, a heat-emitting composition and water, wherein the traditional Chinese medicine composition is composed of safflower, motherwort, rheum officinale, fructus xanthii, trogopterus dung, radix salviae miltiorrhizaeand semen brassicae. The heat-emitting composition is composed of a vermiculite powder, secondary reduced iron, pepper oil and an old ginger powder. The invention also provides a preparation method of the traditional Chinese medicine uterus warming paste. The traditional Chinese medicine uterus warming paste has the main efficacies of reinforcing vital essence and strengthening primordial qi, activating blood circulation to dissipate stasis, warming channels to relieve pain, and removing damp and dispelling cold; the uterus warming paste is capable of warming uterus to relieve pain, and promoting and protecting menstrual hygiene and health, also has the functions of harmonizing qi-blood, improving microcirculation, warming uterus, protecting yin, warming channels and activating blood circulation, maintaining ovary and promoting uterine contraction, and comprehensively regulates female reproductive systems.

The invention discloses azulene-sulfonate-containing gynaecological special lotion. The gynaecological special lotion is prepared from azulene sulfonate and metronidazole, wherein every 500 millimetres of lotion comprises 0.05 to 2.5 grams of azulene sulfonate, 1 to 3 grams of metronidazole and the balance of pure water, and further comprises golden cypress, radix sophorae flavescentis, common cnidium fruit and rhizoma atractylodis, wherein every 500 millimetres of lotion comprises 0.05 to 2.5 grams of azulene sulfonate, 1 to 3 grams of metronidazole, 5 to 10 grams of golden cypress, 5 to 10 grams of radix sophorae flavescentis, 10 to 25 grams of common cnidium fruit, 5 to 10 grams of rhizoma atractylodis and the balance of pure water. The azulene sulfonate-containing gynaecological special lotion is easy to prepare and convenient to use, has good effects of diminishing inflammation and relieving itching, can resist bacteria strikingly without side effects, and cannot stimulate mucous membranes and skins. Furthermore, the lotion can relieve and eliminate various unwell symptoms of women caused by episioitis and vaginitis, and also can improve the self disease resistance of a female reproductive system.

The invention discloses a probiotic solid beverage which comprises the following components in percentage by mass: 20-50% of skimmed milk powder, 5-25% of resistant dextrin, 5-20% of galactooligosaccharide, 5-20% of fructo-oligosaccharide, 0-10% of polydextrose, 1-16% of xylitol, 1-20% of blueberry powder, 10-25% of inulin, 0.05-0.5% of lactobacillus plantarum, 0.05-0.5% of lactobacillus casei and0.05-0.5% of streptococcus thermophilus. The invention further discloses a preparation method and an application of the probiotic solid beverage. A survival rate of probiotics of the probiotic solidbeverage within a shelf life is high, and the probiotic solid beverage is good in taste and can reduce an incidence of diseases of female reproductive systems.

Methods and devices to affect types, proportion, quantity, distribution, or proliferation of microorganisms within a female reproductive system.

The invention provides a plant antibacterial gel composition. The plant antibacterial gel composition comprises, by weight, 5-10 parts of red clover extract, 1-5 parts of rose essential oil, 0.5-2 parts of menthol, 0.01-0.1 part of triclosan, 0.05-0.2 part of Carbomer, 5-10 parts of polyethylene glycol, 1-5 parts of ethanol and 40-50 parts of water, wherein the red clover extract is obtained by pulping blooming red clover plants, filtering and performing supercritical extraction through liquid carbon dioxide. The invention further provides a preparation method of the composition. The plant antibacterial gel composition can regulate female reproductive system functions and eliminate residual solvent damage at the same time.

The invention discloses a medicament for treating hysteromyoma and ovarian cysts, belongs to a traditional Chinese medicine preparation and particularly relates to a medicament for treating diseases of a female reproductive system. The medicament is mainly prepared from the following raw materials in parts by weight: 10 parts of peach seed, 10 parts of safflower, 10 parts of Szechuan lovage rhizome, 30 parts of radix salviae miltiorrhizae, 3 parts of costustoot, 20 parts of nutgrass galingale rhizome, 10 parts of common burreed rhizome, 10 parts of rhizoma zedoariae, 10 parts of eupolyphaga, 10 parts of leech, 10 parts of trogopterus dung, 10 parts of crude pollen typhae, 15 parts of rhizoma corydalis, 15 parts of turmeric root-tuber, 15 parts of cyathula root and 10 parts of Chinese honeylocust spine. Peach seed, safflower, radix salviae miltiorrhizae, eupolyphaga, leech, trogopterus dung, crude pollen typhae, rhizoma corydalis and cyathula root have the effects of promoting blood circulation and removing blood stasis, Szechuan lovage rhizome has the effects of activating qi and removing blood stasis, costustoot, nutgrass galingale rhizome, common burreed rhizome, rhizoma zedoariae and turmeric root-tuber have the effects of activating qi and promoting blood circulation, and Chinese honeylocust spine has the special function of breaking the cysts. Clinic practices prove that the medicament has definite treatment effect and can cure the hysteromyoma and the ovarian cysts generally after a patient take 30-40 doses.